Dr. Samuel A. Allen, DO

Dr. Allen practices at Corewell Health Beaumont Troy Hospital in Troy, Michigan, part of Corewell Health.

Dr. Allen's NPI, 1306861414, was assigned on July 12, 2006. Dr. Allen graduated from Chicago College of Osteopathic Medicine at Midwestern University in 1996. Dr. Allen holds Michigan license 5101013258.

Dr. Allen's primary practice is Corewell Health Beaumont Troy Hospital, at 44201 Dequindre Road, Troy, MI 48085 in Oakland County. The practice phone is (248) 964-8800.

Dr. Allen's primary practice is Corewell Health Beaumont Troy Hospital in Troy, Michigan, part of Corewell Health. Dr. Allen is also affiliated with Corewell Health William Beaumont University Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Allen to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Allen practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Allen's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Allen is board certified in completion by the ACLS/BLS. Dr. Allen is licensed in Michigan.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pneumonia, pulmonary fibrosis, pulmonary heart disease and tobacco use among the conditions Dr. Allen treats.

CMS data shows 1,717 Medicare services from Dr. Allen across 17 procedure codes in 2024, for 602 Medicare patients. Medicare paid $140,127 for them.

CMS counts 602 Medicare patients who saw Dr. Allen in 2024. The largest group is 65 to 74, with 230 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Allen's median patient age at 71, with 51% women.

In 2024, Dr. Allen wrote 1,213 Medicare Part D claims for 222 patients. 35% of them were for generic drugs. CMS names the drug for 1,091 of them, across 24 drugs with 11 or more claims each, at $6,290,930 in total drug cost. In 2023, CMS named 987 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Allen for performance year 2024, reported as part of a group. Dr. Allen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Allen as offering telehealth.

Dmand AI links 2 papers to Dr. Allen.

Dmand AI links Dr. Allen to 4 clinical trials, 2 of them phase 3 studies. Conditions studied include Pulmonary Arterial Hypertension and Hypertension, Pulmonary. United Therapeutics sponsors the most, 2.

CMS Open Payments shows 901 general payments to Dr. Allen from 31 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $243,983.

Dmand AI lists 4 awards for Dr. Allen, most recently Hour Magazine Top Doctor in 2022.

Dr. Allen graduated from Chicago College of Osteopathic Medicine at Midwestern University in 1996. Dr. Allen is a member of ACCP, SCCM, ACP, AMA, AOA and ATS.

Dr. Allen is in network with 12 carriers, including Health Alliance Plan, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.